LEVI MARCELLIN: Open Payments
NPI 1760097794 · TAVARES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 78 payments from 19 companies in 2025. Trend: 2023 $1,218 · 2024 $434 · 2025 $1,477
Food & beverage: $1,477
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $203 |
| GENZYME CORPORATION | 9 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $171 |
| GlaxoSmithKline, LLC. | 15 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $104 |
| Insmed, Inc. | 4 | $96 |
| ABBVIE INC. | 3 | $76 |
| Verona Pharma, Inc. | 4 | $74 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| HARMONY BIOSCIENCES LLC | 2 | $55 |
Products named: DUPIXENT, GLASSIA, NUCALA, Arikayce, Ohtuvayre, JASCAYD, WINREVAIR, WAKIX.
Industry payments across FL — which companies pay providers there.
